Skip to main content
. 2022 Sep;10(17):925. doi: 10.21037/atm-22-3484

Table 3. Univariate analysis of the association between LOX family gene polymorphisms and multiple IAs ruptures.

Gene SNP Genotype Dominant model Recessive model Additive model
Ruptured (n) Unruptured (n) OR (95% CI) P OR (95% CI) P OR (95% CI) P
LOX rs1800449(C>T) 35/25/5 39/28/4 1.05 (0.53–2.05) 0.899 1.40 (0.36–5.44) 0.631 1.09 (0.63–1.87) 0.767
rs2956540(G>C) 27/27/11 31/33/7 1.09 (0.55–2.15) 0.803 1.86 (0.68–5.14) 0.23 1.22 (0.74–1.99) 0.437
rs10519694(C>T) 53/9/3 59/9/3 1.11 (0.46–2.69) 0.812 1.10 (0.21–5.64) 0.912 1.08 (0.56–2.08) 0.824
rs2303656(G>T) 55/10/0 60/11/0 0.99 (0.39–2.52) 0.986 0.99 (0.39–2.52) 0.986
rs763497(A>G) 45/16/4 51/17/3 1.13 (0.54–2.37) 0.740 1.49 (0.32–6.91) 0.613 1.15 (0.64–2.06) 0.646
rs3900446(A>G) 51/14/0 51/17/2 0.70 (0.32–1.54) 0.374 0.65 (0.31–1.35) 0.248
LOXL1 rs2165241(C>T) 43/23/0 60/10/1 2.99 (1.32–6.78) 0.009* 2.53 (1.16–5.56) 0.020*
rs3825942(G>A) 46/18/1 52/16/3 1.13 (0.53–2.39) 0.749 0.35 (0.04–3.49) 0.374 0.99 (0.52–1.89) 0.981
rs2304721(C>A) 43/21/1 39/28/4 0.62 (0.31–1.25) 0.183 0.26 (0.03–2.41) 0.236 0.61 (0.33–1.13) 0.117
rs12441130(T>C) 28/31/6 36/26/9 1.36 (0.69–2.67) 0.374 0.70 (2.24–2.09) 0.523 1.10 (0.67–1.81) 0.717
LOXL2 rs2294128(C>T) 47/17/1 53/17/1 1.13 (0.53–2.42) 0.757 1.09 (0.07–17.85) 0.950 1.11 (0.55–2.24) 0.765
rs7818494(A>G) 44/19/2 39/28/4 0.58 (0.29–1.17) 0.129 0.53 (0.09–3.01) 0.475 0.63 (0.34–1.14) 0.126
rs4323477(A>G) 21/30/14 18/36/17 0.71 (0.34–1.50) 0.371 0.87 (0.39–1.95) 0.738 0.83 (0.52–1.34) 0.446
rs7818416(G>A) 21/28/16 21/37/13 0.88 (0.43–1.82) 0.731 1.46 (0.64–3.32) 0.371 1.07 (0.67–1.72) 0.771
rs1063582(G>T) 39/16/10 43/25/3 1.02 (0.52–2.04) 0.947 4.12 (1.08–15.71) 0.038* 1.31 (0.78–2.18) 0.306
rs2280936(C>G) 40/20/5 48/20/3 1.30 (0.65–2.64) 0.460 1.89 (0.43–8.24) 0.397 1.30 (0.74–2.29) 0.356
rs2294133(C>T) 46/17/2 42/25/4 0.60 (0.29–1.22) 0.158 0.53 (0.09–3.01) 0.475 0.64 (0.35–1.18) 0.153
rs2280935(A>C) 33/27/5 28/32/11 0.63 (0.32–1.25) 0.185 0.46 (1.15–1.39) 0.166 0.65 (0.39–1.09) 0.102
rs1010156(T>C) 11/41/13 17/38/16 1.55 (0.66–3.61) 0.314 0.86 (0.38–1.96) 0.719 1.11 (0.66–1.87) 0.687
rs142252012(G>A) 64/1/0 68/3/0 0.35 (0.04–3.49) 0.374 0.35 (0.04–3.49) 0.374
LOXL3 rs715407(T>G) 44/20/1 47/22/2 0.94 (0.46–1.91) 0.853 0.54 (0.05–6.09) 0.617 0.90 (0.47–1.72) 0.757
rs6707302(C>T) 46/18/1 51/18/2 1.05 (0.50–2.22) 0.891 0.54 (0.05–6.09) 0.617 0.99 (0.51–1.92) 0.980
rs17010021(T>A) 22/31/12 33/33/5 1.70 (0.85–3.40) 0.135 2.99 (0.99–9.02) 0.052 1.72 (1.03–2.89) 0.039*
rs17010022(C>G) 38/22/5 26/33/12 0.41 (0.21–0.82) 0.011* 0.41 (0.14–1.24) 0.113 0.51 (0.30–0.85) 0.010*
LOXL4 rs3793692(G>A) 18/31/16 17/38/16 0.82 (0.38–1.78) 0.618 1.12 (0.51–2.48) 0.775 0.97 (0.60–1.56) 0.890
rs1983864(G>T) 27/31/7 27/33/11 0.86 (0.43–1.72) 0.676 0.66 (0.24–1.82) 0.419 0.84 (0.51–1.38) 0.480
rs7077266(G>T) 48/14/3 53/17/1 1.04 (0.48–2.25) 0.915 3.39 (0.34–33.41) 0.296 1.16 (0.60–2.24) 0.649

, genotype presented as wild type/heterozygous/homozygous; *, P<0.05. IA, intracranial aneurysm; SNP, single nucleotide polymorphism; OR, odds ratio; CI, confidence interval; −, not available.